LTAS
IDXX icon

Linden Thomas Advisory Services’s Idexx Laboratories IDXX Stock Holding History

Linden Thomas Advisory Services’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.14M Sell
7,872
-128
-2% -$71.8K 0.33% 72
2026
Q1 		$4.5M Buy
8,000
+144
+2% +$92.3K 0.43% 54
2025
Q4 		$5.31M Buy
7,856
+31
+0.4% +$21.1K 0.54% 33
2025
Q3 		$5M Buy
7,825
+28
+0.4% +$17K 0.51% 39
2025
Q2 		$4.18M Buy
7,797
+66
+0.9% +$31.6K 0.46% 48
2025
Q1 		$3.25M Buy
7,731
+295
+4% +$128K 0.42% 51
2024
Q4 		$3.07M Buy
7,436
+169
+2% +$74.1K 0.39% 59
2024
Q3 		$3.67M Buy
7,267
+158
+2% +$76.8K 0.5% 31
2024
Q2 		$3.46M Buy
7,109
+931
+15% +$467K 0.54% 26
2024
Q1 		$3.34M Buy
6,178
+233
+4% +$127K 0.54% 24
2023
Q4 		$3.3M Buy
5,945
+328
+6% +$154K 0.62% 14
2023
Q3 		$2.46M Buy
5,617
+771
+16% +$384K 0.55% 19
2023
Q2 		$2.43M Buy
4,846
+144
+3% +$69K 0.54% 30
2023
Q1 		$2.35M Buy
4,702
+115
+3% +$55K 0.58% 28
2022
Q4 		$1.87M Buy
+4,587
New +$1.78M 0.53% 39

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Linden Thomas Advisory Services's IDXX Position: Q2 2026 in Review

Linden Thomas Advisory Services reduced its Idexx Laboratories (IDXX) stake by 1.6% in Q2 2026, selling an estimated $71.8K and leaving 7,872 shares worth $4.14M. The position accounts for 0.33% of the portfolio, ranked #72.

Linden Thomas Advisory Services first reported a position in IDXX in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.31M in Q4 2025. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Linden Thomas Advisory Services held 7,872 shares of Idexx Laboratories worth $4.14M as of Q2 2026.
  • Linden Thomas Advisory Services sold 128 Idexx Laboratories shares in Q2 2026, an estimated $71.8K.
  • Idexx Laboratories made up 0.33% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #72 holding.
  • Linden Thomas Advisory Services first reported a position in Idexx Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Linden Thomas Advisory Services's Idexx Laboratories position peaked at $5.31M in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.